SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS. Int. Res. J. Pharm. [Internet]. 2026 Sep. 19 [cited 2026 Sep. 19];17(9):11-7. Available from: https://irjponline.org/index.php/irjp/article/view/3667